Committed to tackling conditions commonly associated with aging, Cellmid is leveraging innovative technologies against important targets for the development of consumer and pharmaceutical products.

Connecting health and beauty, Cellmid’s mission is to provide solutions for youthful aging.

Committed to tackling conditions commonly associated with aging, Cellmid is leveraging innovative technologies against important targets for the development of consumer and pharmaceutical products.

Connecting health and beauty, Cellmid’s mission is to provide solutions for youthful aging.

Focusing on growing shareholder value

Fast growing consumer business

Anti-aging functional cosmetics and consumer health products for hair, face and wellbeing.

High value drug development assets

Extensive intellectual property surrounding the novel target midkine, an important driver and modulator of inflammatory diseases

Corporate
information

Cellmid is an Australian Company listed on the Australian Stock exchange
ASX: CDY

Cellmid is developing first in class and best in class solutions to a range of conditions associated with aging. Cellmid’s consumer health division, Advangen Limited, develops, manufactures and markets innovative products for hair loss, thinning and hair aging  with rapidly growing operations in Australia, Japan, the USA,  Europe and Asia. Through its wholly owned subsidiary Lyramid Limited, Cellmid is developing treatments for inflammatory and autoimmune conditions.

Today's Share Price

>> More Share Information

Broker Insights

Get an in-depth profile of Cellmid Limited (CDY) share information by Small Cap Insider.

>> View Cellmid Limited Profile

Cellmid in the media

Media coverage of Cellmid’s drug development and consumer health divisions

Media coverage

Shop évolis®